Notification of Interim Resul

RNS Number : 8320F

Allergy Therapeutics PLC

20 January 2010

 

Wednesday 20 January 2010

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Notification of Interim Results and Trading update

Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, will announce its interim results for the six months ended 31 December 2009 on 1 March 2010. The Company expects to report net sales of £27.3m; in line with market expectations.

Historically, Allergy Therapeutics' sales are heavily skewed towards the first half of the Company's financial year.

For further information

Allergy Therapeutics	[phone]
Ian Postlethwaite Finance Director
Manuel Llobet Chief Executive Officer
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Clare Terlouw

 

END

 

 

TSTBMMPTMBITMAM